Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (3)
- (-) Biomedical (1)
- (-) Materials Science (2)
- (-) Microscopy (1)
- 3-D Printing/Advanced Manufacturing (1)
- Bioenergy (2)
- Computer Science (11)
- Cybersecurity (4)
- Energy Storage (1)
- Exascale Computing (1)
- Frontier (5)
- Grid (1)
- High-Performance Computing (2)
- Machine Learning (1)
- National Security (1)
- Neutron Science (1)
- Physics (1)
- Quantum Computing (3)
- Quantum Science (4)
- Security (1)
- Summit (6)
- Sustainable Energy (2)
Media Contacts
A world-leading researcher in solid electrolytes and sophisticated electron microscopy methods received Oak Ridge National Laboratory’s top science honor today for her work in developing new materials for batteries. The announcement was made during a livestreamed Director’s Awards event hosted by ORNL Director Thomas Zacharia.
The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.
A multi-institutional team became the first to generate accurate results from materials science simulations on a quantum computer that can be verified with neutron scattering experiments and other practical techniques.
Processes like manufacturing aircraft parts, analyzing data from doctors’ notes and identifying national security threats may seem unrelated, but at the U.S. Department of Energy’s Oak Ridge National Laboratory, artificial intelligence is improving all of these tasks.
OAK RIDGE, Tenn., May 7, 2019—Energy Secretary Rick Perry, Congressman Chuck Fleischmann and lab officials today broke ground on a multipurpose research facility that will provide state-of-the-art laboratory space
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.